Noble gases are chemically inert,
and it was therefore thought
they would have little effect on biology. Paradoxically, it was found
that they do exhibit a wide range of biological effects, many of which
are target-specific and potentially useful and some of which have
been demonstrated in vivo. The underlying mechanisms by which useful
pharmacology, such as tissue and neuroprotection, anti-addiction effects,
and analgesia, is elicited are relatively unexplored. Experiments
to probe the interactions of noble gases with specific proteins are
more difficult with gases than those with other chemicals. It is clearly
impractical to conduct the large number of gas–protein experiments
required to gain a complete picture of noble gas biology. Given the
simplicity of atoms as ligands, in silico methods provide an opportunity
to gain insight into which noble gas–protein interactions are
worthy of further experimental or advanced computational investigation.
Our previous validation studies showed that in silico methods can
accurately predict experimentally determined noble gas binding sites
in X-ray structures of proteins. Here, we summarize the largest reported
in silico reverse docking study involving 127 854 protein structures
and the five nonradioactive noble gases. We describe how these computational
screening methods are implemented, summarize the main types of interactions
that occur between noble gases and target proteins, describe how the
massive data set that this study generated can be analyzed (freely
available at group18.csiro.au), and provide the NDMA receptor as an
example of how these data can be used to understand the molecular
pharmacology underlying the biology of the noble gases. We encourage
chemical biologists to access the data and use them to expand the
knowledge base of noble gas pharmacology, and to use this information,
together with more efficient delivery systems, to develop “atomic
drugs” that can fully exploit their considerable and relatively
unexplored potential in medicine.